Comprehensive Epilepsy Program News Today

Pharmacology research team reveals breakthrough findings on cannabinoid therapy for preventing epilepsy and refractory seizure disorders

An obscure bit of brain tissue appears critical to both out-of-body experiences and our sense of being anchored to a physical self.

Adolescents newly diagnosed with focal epilepsy have a high rate of suicidality that increases even more over time.

Learn how the neurology team at Arkansas Childrens Northwest diagnoses and treats both seizures and epilepsy.

“Seizure frequency improves in patients with epilepsy participating in clinical drug studies even when they do not continue to receive the experimental drug,” said Nathan Fountain, M.D., Associate Professor of Neurology at the University of Virginia, School of Medicine and Director of the FE Dreifuss Comprehensive Epilepsy Program, today at the 58th annual AES conference in

One of the many possible side effects of antiepileptic drugs is a change in weight. Valproate, in particular, has been associated with weight gain. However, a recent study by Patricio Espinosa, MD, MPH, presented at the 58th Annual Meeting of the American Academy of Neurology, San Diego suggests that weight gain with valproate may be a problem for teenagers and adults, but not

A retrospective analysis indicates a need for extra vigilance among patients with a seizure disorder or other chronic condition, even when they are in familiar places, researchers say.